Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(11C)PE2I----1件: 6 💬
2(2-chloro-5-[11C]methoxy-N-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide)----1件: 6 💬
3(3beta, 5beta, 25R)-spirostan-3-ol----1件: 6 💬
4(3ß, 5ß, 25R)-spirostan-3-ol----1件: 6 💬
5(6S)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol----1件: 6 💬
6(minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate----1件: 6 💬
7(R)-troloxamide quinone----1件: 6 💬
8(S)- 2- Amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol----1件: 6 💬
9(S)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate----1件: 6 💬
100 mg tropicamide1件: Tropicamide1件: Tropicamide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
110.04 mg Lu AE04621----1件: 6 💬
120.08 mg Lu AE04621----1件: 6 💬
130.2 mg Lu AE04621----1件: 6 💬
140.3 mg tropicamide1件: Tropicamide1件: Tropicamide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
150.4 mg Lu AE04621----1件: 6 💬
160.6 mg Lu AE04621----1件: 6 💬
170.8 mg Lu AE04621----1件: 6 💬
180.9% saline----2件: 6, 70 💬
190.9% sodium chloride2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬 --4件: 6, 14, 51, 53 💬
200.9% sodium chloride (normal saline)2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬 --1件: 6 💬
2100000----2件: 6, 96 💬
22000000----1件: 6 💬
23009-0----1件: 6 💬
24009-1----1件: 6 💬
25009-2----1件: 6 💬
26009-3----1件: 6 💬
27009-4----1件: 6 💬
28009-5----1件: 6 💬
29009-A0----1件: 6 💬
30009-A1----1件: 6 💬
31009-A2----1件: 6 💬
32009-A3----1件: 6 💬
33023145028----1件: 6 💬
34043906039----1件: 6 💬
351 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
361 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
371 mg tropicamide1件: Tropicamide1件: Tropicamide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
381. Tesofensine (NS 2330)1件: Tesofensine---1件: 6 💬
391.0 mg Lu AE04621----1件: 6 💬
401.0 mg rasagiline mesylate1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
411.2 mg Lu AE04621----1件: 6 💬
42100----2件: 6, 97 💬
4311C-ACETATE2件: Acetate,
Acetic acid C-11		---4件: 6, 13, 86, 88 💬
4411C-MC1----1件: 6 💬
4511C-PBR28----2件: 6, 13 💬
4611C-PiB----2件: 6, 13 💬
4711C-PS13----2件: 6, 13 💬
4811C-Raclopride1件: Raclopride---1件: 6 💬
4911C]PBR28----1件: 6 💬
5011C]SMW139----1件: 6 💬
51125----1件: 6 💬
5213N-Ammonia1件: Ammonia1件: Ammonia solution, strong 💬 --1件: 6 💬
5313N-Amonia----1件: 6 💬
5415 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5515 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5615-0 H20----2件: 6, 19 💬
5715O H2O----1件: 6 💬
5815O]H2O----1件: 6 💬
5918-FDTBZ----1件: 6 💬
6018F florbetaben----1件: 6 💬
6118F- DTBZ----1件: 6 💬
6218F-AV-1331件: Florbenazine F-18---1件: 6 💬
6318F-AV-45----2件: 6, 127 💬
6418F-DOPA----2件: 6, 75 💬
6518F-DOPA PET----1件: 6 💬
6618F-DTBZ----1件: 6 💬
6718F-DTBZ AV-133----1件: 6 💬
6818F-FDG1件: Fludeoxyglucose (18F)---8件: 5, 6, 7, 13, 84, 85, 127, 300 💬
6918f-florbetaben----1件: 6 💬
7018F-Fluoro-L-dopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
7118F] LBT-999----1件: 6 💬
7218F]-(E)-N-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane----1件: 6 💬
7318F]FE-PE2I----1件: 6 💬
7418F]MC225----1件: 6 💬
751[(6- Allyl- 8beta- erg----1件: 6 💬
761[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-----1件: 6 💬
771[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6 💬
781[(6- Allyl- 8ß- erg----1件: 6 💬
791[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-----1件: 6 💬
801[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6 💬
812 mg perampanel1件: Perampanel1件: Perampanel 💬 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬 		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 6 💬
822,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide----1件: 6 💬
832-[[[(2R)-1-[1-[(4-CHLORO-3-METHYLPHENYL)METHYL]-4- PIPERIDINYL]-5-OXO-2-PYRROLIDINYL]CARBONYL]AMINO]- N,N,6-TRIMETHYL-4-PYRIDINECARBOXAMIDE,DIHYDROCHLORIDE----2件: 6, 162 💬
84200 mg BIA 6-5121件: BIA---1件: 6 💬
85207-3120----1件: 6 💬
86240mg Amantadine HCl ER tablets1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
8725 mg BIA9 1067----1件: 6 💬
8825 mg Ongentys1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
8925330----1件: 6 💬
903 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
913 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
923 mg tropicamide1件: Tropicamide1件: Tropicamide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
933- (9,10- Didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate----1件: 6 💬
943-(3,4-Dihydroxyphenyl)-L-alanine1件: Alanine1件: Alanine 💬 --1件: 6 💬
95320mg Amantadine HCl ER tablets1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
964 mg perampanel1件: Perampanel1件: Perampanel 💬 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬 		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 6 💬
9750 mg BIA 9 10671件: BIA---1件: 6 💬
9850 mg Ongentys1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
996-[18F]Fluorodopa----1件: 6 💬
1006-[18F]Fluorodopamine----1件: 6 💬
1016036937.00.01----1件: 6 💬
1026abeta - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1036aß - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1047 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1057 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1067-beta-Hydroxyepiandrosterone1件: 7-beta-Hydroxyepiandrosterone---1件: 6 💬
10775----1件: 6 💬
1088-OHdG1件: 8-hydroxy-2'-deoxyguanosine---1件: 6 💬
109[11C]-PIB----1件: 6 💬
110[11C]PXT012253----1件: 6 💬
111[123I] 5-IA----1件: 6 💬
112[123I] IBVM and SPECT imaging----1件: 6 💬
113[123I] mZINT injection and serial dynamic SPECT imaging----1件: 6 💬
114[123I]-IBVM----1件: 6 💬
115[123I]B-CIT----1件: 6 💬
116[123I]B-CIT SPECT imaging----1件: 6 💬
117[123I]beta CIT----1件: 6 💬
118[123I]beta CIT and SPECT imaging----1件: 6 💬
119[123I]beta-CIT----1件: 6 💬
120[123I]beta-CIT and SPECT imaging----1件: 6 💬
121[123I]CLINDE----2件: 6, 13 💬
122[123I]MNI-420----2件: 6, 8 💬
123[123I]ß CIT----1件: 6 💬
124[123I]ß CIT and SPECT imaging----1件: 6 💬
125[123I]ß-CIT----1件: 6 💬
126[123I]ß-CIT and SPECT imaging----1件: 6 💬
127[14C]-BIA 9-10671件: BIA---1件: 6 💬
128[18F] CFPyPB----1件: 6 💬
129[18F] LBT-999 PET----1件: 6 💬
130[18F] PBR06----2件: 6, 13 💬
131[18F] PI-2620----1件: 6 💬
132[18F]-FEPPA----2件: 6, 13 💬
133[18F]DPA-714 PET scan----1件: 6 💬
134[18F]FDOPA----2件: 6, 17 💬
135[18F]FDOPA PET/CT----1件: 6 💬
136[18F]FPEB----3件: 6, 8, 206 💬
137[18F]MK-9470----1件: 6 💬
138[18F]MNI-1126----1件: 6 💬
139[18F]MPPF----1件: 6 💬
140[18F]P17-059----1件: 6 💬
141[18F]PI-2620----2件: 6, 127 💬
142[18F]T807 ([18F]MNI-777)----2件: 5, 6 💬
143[18F]UCB-2897----1件: 6 💬
144[21CFR640.30] Plasma from 18 - 25 year old volunteer donors----1件: 6 💬
145A-dopamine1件: Dopamine1件: Dopamine 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
146Aadipose-Derived Mesenchymal Stem Cells----1件: 6 💬
147AAV-GAD Dose 1----1件: 6 💬
148AAV-GAD Dose 2----1件: 6 💬
149AAV-hAADC-2----1件: 6 💬
150AAV2-GDNF----1件: 6 💬
151AB1010----6件: 2, 5, 6, 13, 46, 96 💬
152ABBV-0805----1件: 6 💬
153ABBV-951----1件: 6 💬
154ABT-SLV187----1件: 6 💬
155Acamprosate1件: Acamprosate1件: Acamprosate 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 6, 206 💬
156Accordion Pill Carbidopa/Levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
157Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
158Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
159Accordion Pill? Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
160Accordion Pill? Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
161Accordion Pill¿ Carbidopa/levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
162Accordion Pill™ Carbidopa/Levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
163Accordion Pill™ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
164Accordion Pill™ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
165Acetate1件: Acetate---41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
166Acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬 --21件: 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 💬
167Acidophilus1件: Lactobacillus acidophilus1件: Lactomin 💬 --2件: 6, 97 💬
168ACP-103----1件: 6 💬
169ACR3251件: ACR325---1件: 6 💬
170Active comparator----2件: 6, 46 💬
171Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily.----1件: 6 💬
172Active drug: pimavanserin 17mg (2 strength tablets)1件: Pimavanserin---1件: 6 💬
173Active Investigational Treatment ENT-01----1件: 6 💬
174AD-810N (zonisamide)1件: Zonisamide1件: Zonisamide 💬 8件: CACNA1G,
CACNA1H,
CACNA1I,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 💬1件: 6 💬
175Adipose-derived stromal vascular fraction cells----1件: 6 💬
176Adjuvant without active component----2件: 6, 17 💬
177Administration of stable isotope-labelled leucine-1件: Leucine1件: Leucine 💬 --1件: 6 💬
178ADS-5102----2件: 6, 13 💬
179ADS-5102 (extended release amantadine HCl)1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
180ADX48621----1件: 6 💬
181AFFITOPE® PD01A----1件: 6 💬
182AFFITOPE® PD01A + Adjuvant----2件: 6, 17 💬
183AFQ056----3件: 6, 8, 206 💬
184AFQ056 with L-dopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
185AFQ065----1件: 6 💬
186Agomelatine1件: Agomelatine1件: Agomelatine 💬 3件: HTR2C,
MTNR1A,
MTNR1B 💬 		6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
187Agomelatine or PIacebo1件: Agomelatine1件: Agomelatine 💬 3件: HTR2C,
MTNR1A,
MTNR1B 💬 		6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
188AKST4290----2件: 6, 162 💬
189AL----11件: 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127 💬
190Alanine1件: Alanine1件: Alanine 💬 --4件: 6, 13, 298, 299 💬
191Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg)----1件: 6 💬
192Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg)----1件: 6 💬
193Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg)----1件: 6 💬
194Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg)----1件: 6 💬
195Allopurinol1件: Allopurinol1件: Allopurinol 💬 1件: XDH 💬 6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬7件: 6, 46, 57, 60, 66, 96, 97 💬
196AlloRx----8件: 2, 6, 13, 46, 51, 85, 90, 226 💬
197Altropane1件: Altropane---1件: 6 💬
198Altropane (123I) Injection1件: Altropane---1件: 6 💬
199ALTROPANE®1件: Altropane---1件: 6 💬
200Amantadin-ratiopharm 100mg----1件: 6 💬
201AMANTADINE1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬4件: 6, 8, 13, 127 💬
202Amantadine 300 mg1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
203Amantadine HCl ER1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
204Amantadine HCl Extended Release1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
205Amantadine HCl Extended Release Capsule1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
206AMANTADINE HYDROCHLORIDE1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 6, 13 💬
207Amantadine hydrochloride (HCl)1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
208Amantadine sulfate2件: Amantadine,
Sulfate ion		1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
209AMBROSAN 60mg Tablets----1件: 6 💬
210Ambroxol1件: Ambroxol1件: Ambroxol 💬 --2件: 6, 19 💬
211Ambroxol Hydrochloride1件: Ambroxol1件: Ambroxol 💬 --2件: 6, 19 💬
212AMDX2011P----2件: 2, 6 💬
213Ammonia1件: Ammonia1件: Ammonia solution, strong 💬 --2件: 6, 296 💬
214Amoxicillin2件: Amoxicillin,
Clavulanic acid		3件: Amoxicillin ,
Amoxicillin ,
Clavulanic acid 💬 		--7件: 6, 46, 63, 96, 97, 222, 299 💬
215Ampreloxetine1件: Ampreloxetine1件: Ampreloxetine 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17 💬
216Ampreloxetine chydrochloride1件: Ampreloxetine1件: Ampreloxetine 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17 💬
217Ampreloxetine hydrochloride1件: Ampreloxetine1件: Ampreloxetine 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17 💬
218Ampyra1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 6, 13 💬
219Ampyra first,1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 6 💬
220ANAVEX2-73----2件: 6, 156 💬
221ANHYDROUS CARBIDOPA1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
222Anle138b1件: anle138b---1件: 6 💬
223Anti-Parkinson medication----5件: 5, 6, 7, 8, 17 💬
224Anti-Parkinsonian Drugs----1件: 6 💬
225Antiparkinsonian Agent(s)----1件: 6 💬
226AP----4件: 2, 6, 13, 299 💬
227AP-CD/LD----1件: 6 💬
228AP09004----1件: 6 💬
229Apigenin1件: Apigenin---2件: 6, 97 💬
230APL-130277----1件: 6 💬
231Aplindore1件: Aplindore---1件: 6 💬
232Aplindore MR tablets1件: Aplindore---1件: 6 💬
233APO-go----1件: 6 💬
234APO-go®----1件: 6 💬
235APOKINON----1件: 6 💬
236APOKYN1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
237Apomor----1件: 6 💬
238Apomorfina1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
239APOMORFINA CLORIDRATO1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
240Apomorp----1件: 6 💬
241Apomorphine1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 5, 6, 7 💬
242Apomorphine 0.25% (2.5mg/ml)1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
243Apomorphine HCl injection1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
244APOMORPHINE HYDROCHLORIDE1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
245Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
246Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
247Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
248Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
249APOMORPHINE HYDROCHLORIDE HEMIHYDRATE1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
250Apomorphine Hydrocloride1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
251Apomorphine Hydrocloride Hemihydrate1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
252Apomorphine infusion1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
253Apomorphine Injectable Solution1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
254Apomorphine Nasal Powder1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
255APORON----1件: 6 💬
256AQW051----1件: 6 💬
257ARICEPT1件: Donepezil1件: Donepezil 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬4件: 6, 13, 78, 124 💬
258Aricept 5 mg-Filmtabletten----1件: 6 💬
259Aricept 5mg-Filmtabletten----1件: 6 💬
260Aripiprazole1件: Aripiprazole1件: Aripiprazole 💬 4件: DRD2,
DRD3,
HTR1A,
HTR2A 💬 		12件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬2件: 6, 206 💬
261Armodafinil1件: Armodafinil1件: Armodafinil 💬 1件: SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬3件: 6, 13, 84 💬
262Artane----1件: 6 💬
263AS2----1件: 6 💬
264ASyn Mab----1件: 6 💬
265AT 10----2件: 6, 85 💬
266ATH-1017----1件: 6 💬
267ATM FOG in PD----1件: 6 💬
268Atomoxetine1件: Atomoxetine1件: Atomoxetine 💬 1件: SLC6A2 💬 1件: Synaptic vesicle cycle 💬4件: 6, 8, 13, 17 💬
269Atypical Antipsychotics----1件: 6 💬
270Autologous mesenchymal stem cells----5件: 2, 6, 13, 17, 46 💬
271AV-1011件: AV-101---2件: 6, 86 💬
272AVALOX - 400----1件: 6 💬
273AVE8112----1件: 6 💬
274AVP-923----3件: 2, 6, 13 💬
275AVP-923-45----1件: 6 💬
276Azathioprine1件: Azathioprine1件: Azathioprine 💬 --21件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 💬
277AZD0328----1件: 6 💬
278AZD3241----2件: 6, 17 💬
279AZD3241 300 mg BID----1件: 6 💬
280AZD3241 600 mg BID----1件: 6 💬
281AZD3241 Alternative titration scheme with formulation 1 or 2----1件: 6 💬
282AZD3241 ER formulation 1----1件: 6 💬
283AZD3241 Extended release tablets 100 mg1件: Manganese citrate---1件: 6 💬
284AZD3241 Extended release tablets 25 mg1件: Manganese citrate---1件: 6 💬
285Azilect1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬4件: 2, 5, 6, 17 💬
286AZILECT 1 mg comprimidos1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
287Azilect 1mg1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
288AZILECT®1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
289B6, B12, L-methylfolate1件: Levomefolic acid1件: Levomefolic acid 💬 --1件: 6 💬
290Balance1件: Isoxaflutole---5件: 6, 11, 46, 81, 149 💬
291Bavisant1件: Bavisant1件: Bavisant 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
292Bavisant dihydrochloride monohydrate1件: Bavisant1件: Bavisant 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
293BAVISANT HYDROCHLORIDE MONOHYDRATE1件: Bavisant1件: Bavisant 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
294Bee venom----1件: 6 💬
295BEFIRADOL----1件: 6 💬
296BEN-2001----1件: 6 💬
297BENSERAZIDE1件: Benserazide1件: Benserazide 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
298BENSERAZIDE HYDROCHLORIDE1件: Benserazide1件: Benserazide 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
299Benzofuran1件: Benzofuran---1件: 6 💬
300Berachin----1件: 6 💬
301Best Medical Treatment----1件: 6 💬
302Best médical treatment----1件: 6 💬
303Betaquik MCT supplement----1件: 6 💬
304BF 2.649----1件: 6 💬
305BF 2.649 10 mg----1件: 6 💬
306BF 2.649 20 mg----1件: 6 💬
307BF 2.649 40 mg----1件: 6 💬
308BF 2.649 5 mg----1件: 6 💬
309BF2.649----1件: 6 💬
310BF2.649 (Pitolisant)1件: Pitolisant1件: Pitolisant 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
311BI-Sifrol®----1件: 6 💬
312BIA1件: BIA---2件: 6, 86 💬
313BIA 3-2021件: BIA---1件: 6 💬
314BIA 3-202 (200 mg)1件: BIA---1件: 6 💬
315BIA 6-5121件: BIA---1件: 6 💬
316BIA 6-512 100 mg1件: BIA---1件: 6 💬
317BIA 6-512 100 mg dose1件: BIA---1件: 6 💬
318BIA 6-512 200 mg dose1件: BIA---1件: 6 💬
319BIA 6-512 25 mg1件: BIA---1件: 6 💬
320BIA 6-512 25 mg dose1件: BIA---1件: 6 💬
321BIA 6-512 400 mg1件: BIA---1件: 6 💬
322BIA 6-512 50 mg dose1件: BIA---1件: 6 💬
323BIA 9-10671件: BIA---1件: 6 💬
324BIA 9-1067 (test)1件: BIA---1件: 6 💬
325BIA 9-1067 15 mg1件: BIA---1件: 6 💬
326BIA 9-1067 25 mg1件: BIA---1件: 6 💬
327BIA 9-1067 30 mg1件: BIA---1件: 6 💬
328BIA 9-1067 5 mg1件: BIA---1件: 6 💬
329BIA 9-1067 micronized1件: BIA---1件: 6 💬
330BIA 9-1067 non-micronized1件: BIA---1件: 6 💬
331BIIB014----1件: 6 💬
332BIIB054----1件: 6 💬
333BIIB094----1件: 6 💬
334BIIB122----1件: 6 💬
335Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus----1件: 6 💬
336Biological/Vaccine: Allogeneic HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---1件: 6 💬
337Biomarker identification in Parkinson disease----1件: 6 💬
338Bisphosphonates----2件: 6, 274 💬
339Blood draw----1件: 6 💬
340Blood Sampling and DNA collection----1件: 6 💬
341Bone marrow derived mesenchymal stem cells----2件: 6, 60 💬
342BoNT-A----1件: 6 💬
343Botox1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬7件: 2, 6, 13, 47, 51, 149, 226 💬
344Botulinum Toxin----3件: 6, 13, 149 💬
345BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 💬
346Botulinum toxin type B1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬3件: 2, 6, 51 💬
347Botulinum toxin type B (Myobloc)1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬2件: 2, 6 💬
348Botulinum Toxin: Xeomin1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
349BROMOCRIPTINE1件: Bromocriptine1件: Bromocriptine 💬 2件: DRD2,
PRL 💬 		12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 74 💬
350Bromocriptine and other dopamine agonists2件: Bromocriptine,
Dopamine		2件: Bromocriptine ,
Dopamine 💬 		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
PRL 💬 		15件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
351BTRX-2460401件: BTRX-246040---1件: 6 💬
352BTX-A1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
353Bumetanide1件: Bumetanide1件: Bumetanide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬2件: 6, 158 💬
354Bumetanide white, oblong, scored tablet1件: Bumetanide1件: Bumetanide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6 💬
355Buntanetap----1件: 6 💬
356Bupleurum+Ginkgo1件: Ginkgo biloba---1件: 6 💬
357Buspirone1件: Buspirone1件: Buspirone 💬 2件: DRD2,
HTR1A 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬2件: 6, 51 💬
358Buspirone Hydrochloride1件: Buspirone1件: Buspirone 💬 2件: DRD2,
HTR1A 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
359Butylphthalide1件: Butylphthalide---4件: 2, 6, 18, 22 💬
360BYDUREON1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 6, 17 💬
361Bydureon 2 mg powder and solvent for prolonged-release suspension2件: Exenatide,
Manganese citrate		1件: Exenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
362Byetta1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 6, 78, 193 💬
363Byetta 5 micrograms1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
364Cabaser----1件: 6 💬
365Cabaseril----1件: 6 💬
366Cabaseril, 1,0 mg Tablette----1件: 6 💬
367Cabaseril, 2,0 mg Tablette----1件: 6 💬
368CABERGOLINA1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 75 💬
369Cabergoline1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 74, 75 💬
370Caffeine1件: Caffeine2件: Caffeine ,
Caffeine hydrate 💬 		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 2, 6, 21, 46, 78, 96, 97, 265 💬
371Caffeine 100-200 mg BID1件: Caffeine2件: Caffeine ,
Caffeine hydrate 💬 		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
372Caffeine alkaloid1件: Caffeine2件: Caffeine ,
Caffeine hydrate 💬 		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
373Calcium2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--27件: 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
374Cannabidiol1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬18件: 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
375Cannabidiol (CBD)1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬7件: 6, 13, 140, 144, 145, 156, 158 💬
376Cannabis1件: Medical Cannabis---7件: 2, 6, 13, 19, 90, 96, 97 💬
377Cannabis Oil1件: Medical Cannabis---1件: 6 💬
378Cannabis, Medical1件: Medical Cannabis---5件: 2, 6, 13, 96, 97 💬
379Capsaicin1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬3件: 6, 86, 226 💬
380Capsaicin vapor1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 6 💬
381Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
382Carbamazepine1件: Carbamazepine1件: Carbamazepine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 6, 13, 231 💬
383CARBIDOPA1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬7件: 6, 13, 17, 90, 140, 164, 201 💬
384CARBIDOPA (CD)1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
385CARBIDOPA (FU)1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
386Carbidopa 20 mg1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
387Carbidopa 200mg oral dose1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
388Carbidopa 27.5 mg1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
389Carbidopa 65 mg capsule1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
390Carbidopa and Levodopa 25mg/100mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
391Carbidopa and Levodopa Controlled Release Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
392Carbidopa and Levodopa Tablets, USP2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
393CARBIDOPA ANIDRA1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
394CARBIDOPA FU1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
395CARBIDOPA INN1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
396CARBIDOPA LEVODOPA2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
397CARBIDOPA MONOHYDRATE1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
398Carbidopa Pill1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
399Carbidopa, levodopa, entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
400Carbidopa- Levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
401Carbidopa-4'-Monophosphate1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
402Carbidopa-Levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
403Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
404Carbidopa/l-dopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
405Carbidopa/l-dopa/entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
406Carbidopa/levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
407Carbidopa/levodopa, as prescribed by treating physician2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
408Carbidopa/Levodopa, immediate release2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
409Carbidopa/Levodopa/Entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
410Carbidopamonohydraat----1件: 6 💬
411CARBODOPA LEVADOPA----1件: 6 💬
412Carbodopa/levadopa----1件: 6 💬
413Carbon1件: Activated charcoal---6件: 6, 85, 86, 96, 97, 158 💬
414Carbon-14 BIA 28-61562件: Activated charcoal,
BIA		---1件: 6 💬
415Carnosine1件: Carnosine---2件: 6, 13 💬
416Carnosine supplementation1件: Carnosine---1件: 6 💬
417Catapres ampoules1件: Clonidine1件: Clonidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
418CBD----13件: 2, 6, 8, 13, 36, 46, 51, 140, 144, 145, 156, 158, 206 💬
419CD----8件: 6, 13, 46, 51, 63, 96, 97, 265 💬
420CD-LD CR----1件: 6 💬
421CD-LD IR----1件: 6 💬
422CDNF----1件: 6 💬
423Ceftriaxone1件: Ceftriaxone1件: Ceftriaxone 💬 --4件: 2, 6, 46, 97 💬
424CEP-13471件: CEP-1347---1件: 6 💬
425CEP-1347 10mg1件: CEP-1347---1件: 6 💬
426CEP-1347 50mg1件: CEP-1347---1件: 6 💬
427CEP1347----1件: 6 💬
428CEP1347 25mg----1件: 6 💬
429CERE-120----1件: 6 💬
430CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])----1件: 6 💬
431CERE-120: AAV2-NTN----1件: 6 💬
432CERE-120: Adeno-Associated Virus Delivery of Neurturin----1件: 6 💬
433Cerebral Dopamine Neurotrophic Factor1件: Dopamine1件: Dopamine 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
434Ceretec2件: Cobalt chloride,
Technetium Tc-99m exametazime		---1件: 6 💬
435CERETEC (TM) Estabilizado2件: Cobalt chloride,
Technetium Tc-99m exametazime		---1件: 6 💬
436Chamomile1件: Chamomile1件: German chamomile flower 💬 --1件: 6 💬
437Champix1件: Varenicline1件: Varenicline 💬 2件: CHRNA4,
CHRNB2 💬 		4件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬1件: 6 💬
438Chinese herbal medicine treatment----1件: 6 💬
439Chloride1件: Chloride ion---28件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬
440Chocolate1件: Cocoa---1件: 6 💬
441CIPRALEX----1件: 6 💬
442Circadin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬3件: 6, 13, 90 💬
443Circadin®1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
444Citalopram1件: Citalopram1件: Citalopram 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬7件: 6, 8, 13, 18, 46, 98, 127 💬
445Citalopram 20mg1件: Citalopram1件: Citalopram 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
446Citicolin----1件: 6 💬
447CITICOLIN*1G/4ML IM IV 5 F----1件: 6 💬
448Citicolina1件: Citicoline1件: Citicoline 💬 --1件: 6 💬
449Citicolina 1000 mg/die1件: Citicoline1件: Citicoline 💬 --1件: 6 💬
450CITICOLINA SODICA1件: Citicoline1件: Citicoline 💬 --1件: 6 💬
451CJH1 (CLR4001)----1件: 6 💬
452Clarithromycin1件: Clarithromycin1件: Clarithromycin 💬 --8件: 6, 63, 84, 96, 97, 222, 228, 299 💬
453Clarithromycin (Not used as of 4/2020)1件: Clarithromycin1件: Clarithromycin 💬 --1件: 6 💬
454Clarium 50 mg Retardtabletten----1件: 6 💬
455Clartihromycin, amoxicillin, and omeprazole2件: Amoxicillin,
Omeprazole		3件: Amoxicillin ,
Omeprazole ,
Amoxicillin 💬 		2件: ATP4A,
ATP4B 💬 		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 6 💬
456CLE----1件: 6 💬
457Clenbuterol1件: Clenbuterol1件: Clenbuterol 💬 1件: ADRB2 💬 9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 1, 2, 6, 256 💬
458Clenbuterol HCl1件: Clenbuterol1件: Clenbuterol 💬 1件: ADRB2 💬 9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
459CLENBUTEROL HYDROCHLORIDE1件: Clenbuterol1件: Clenbuterol 💬 1件: ADRB2 💬 9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
460Clonazepam1件: Clonazepam1件: Clonazepam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
461Clonidine1件: Clonidine1件: Clonidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬4件: 6, 65, 70, 78 💬
462Clonidine hydrochloride1件: Clonidine1件: Clonidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 6, 78 💬
463CLOZAPINE1件: Clozapine1件: Clozapine 💬 11件: ADRA2A,
ADRA2B,
ADRA2C,
DRD4,
HTR2A,
HTR2C,
HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬 		8件: Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬1件: 6 💬
464Coarse wheat bran2件: Wheat,
Wheat bran		1件: Wheat 💬 --1件: 6 💬
465Cocoa1件: Cocoa---1件: 6 💬
466Coenzyme Q101件: Ubidecarenone1件: Ubidecarenone 💬 --11件: 2, 5, 6, 8, 10, 18, 46, 57, 113, 214, 215 💬
467Coenzyme Q10 Nanodispersion (Nanoquinone)1件: Ubidecarenone1件: Ubidecarenone 💬 --1件: 6 💬
468Coenzyme Q10 with vitamin E2件: Ubidecarenone,
Vitamin E		2件: Ubidecarenone ,
Vitamin E 💬 		--1件: 6 💬
469Cogane----1件: 6 💬
470Cogane™ (PYM50028)----1件: 6 💬
471Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
472Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1)1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
473Cohort1----1件: 6 💬
474Cohort2----1件: 6 💬
475Collection of biological sample (blood and/or CSF)----2件: 2, 6 💬
476Combination injection of EPO and G-CSF1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 6 💬
477Combination Product: L-dopa 140 mg1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
478Combination Product: L-dopa 35 mg1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
479Combination Product: L-dopa 70mg1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
480Combination Product: L-dopa 70mg/carbidopa 7mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
481Combination Product: ND0612 Solution for SC infusion----1件: 6 💬
482Combination Product: Sanacoach Parkinson (SCP)----1件: 6 💬
483Comparator: carbidopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
484Comparator: levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
485COMTAN1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
486COMTAN 200* 60 CPR 200 MG1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
487COMTAN®1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
488Comtan®----1件: 6 💬
489Comtess1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
490Comtess®----1件: 6 💬
491Conscious sedation----1件: 6 💬
492Continuous Apomorphine infusion1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
493Continuous intrajejunal infusion of levodopa-carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
494Continuous Release Dopamine Agonists1件: Dopamine1件: Dopamine 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
495Continuous Subcutaneous Lisuride Infusion1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
496Control----4件: 6, 46, 168, 299 💬
497Controlled-release levodopa / carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
498Convection enhanced delivery/AAV2-GDNF----1件: 6 💬
499Conventional medication----1件: 6 💬
500CoQ10----3件: 5, 6, 8 💬
501Cortef2件: Hydrocortisone,
Hydrocortisone cypionate		2件: Hydrocortisone ,
Hydrocortisone cypionate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 6, 81, 83 💬
502CP----6件: 6, 46, 96, 97, 107, 271 💬
503CPL500036----1件: 6 💬
504CPL500036 - high dose----1件: 6 💬
505CPL500036 - low dose----1件: 6 💬
506Creatine1件: Creatine---11件: 1, 2, 5, 6, 8, 46, 49, 50, 113, 156, 201 💬
507Crocin1件: Crocin---1件: 6 💬
508Crocin and Apigenin2件: Apigenin,
Crocin		---1件: 6 💬
509CST-103----1件: 6 💬
510CST-107----1件: 6 💬
511CST-139----1件: 6 💬
512Cu(II)ATSM----2件: 2, 6 💬
513CVD00118-E----1件: 6 💬
514CVL-751----1件: 6 💬
515CVN424----1件: 6 💬
516CVT-301----1件: 6 💬
517CVT-301 (Dose Level 1)----1件: 6 💬
518CVT-301 (Dose Level 2)----1件: 6 💬
519CVT-301 35mg----1件: 6 💬
520CVT-301 50mg----1件: 6 💬
521CVT-301 High Dose----1件: 6 💬
522CVT-301 Low Dose----1件: 6 💬
523CVT-301, LIP----1件: 6 💬
524CVXL-0107----1件: 6 💬
525CX-8998----1件: 6 💬
526CyberKnife----1件: 6 💬
527CYMBALTA1件: Duloxetine1件: Duloxetine 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬3件: 6, 13, 49 💬
528Cystoscopic injection of Botox into the urinary bladder1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
529D-Serine2件: D-Serine,
Serine		1件: Serine 💬 --1件: 6 💬
530D-serine (~2g/day)2件: D-Serine,
Serine		1件: Serine 💬 --1件: 6 💬
531DA-9701----1件: 6 💬
532DA-9805 45mg----1件: 6 💬
533DA-9805 90mg----1件: 6 💬
534Dacepton 5 mg/ml----1件: 6 💬
535Dacepton 5 mg/ml infuusioneste, liuos----1件: 6 💬
536Daily ingestion of Lactobacillus plantarum PS1281件: Lactobacillus plantarum---1件: 6 💬
537Darifenacin1件: Darifenacin1件: Darifenacin 💬 1件: CHRM3 💬 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬2件: 6, 13 💬
538Dark chocolate (85% cocoa)1件: Cocoa---1件: 6 💬
539DaTSCAN1件: Ioflupane I-123---3件: 2, 5, 6 💬
540DaTSCAN 74 MBq/ml solution for injection1件: Ioflupane I-123---1件: 6 💬
541DC158AM----1件: 6 💬
542DCI----2件: 6, 299 💬
543Deanol1件: Deanol1件: Deanol 💬 --1件: 6 💬
544Deanol pyroglutamate1件: Deanol1件: Deanol 💬 --1件: 6 💬
545DEBRUMYL----1件: 6 💬
546DEFERIPRONE1件: Deferiprone1件: Deferiprone 💬 --6件: 2, 6, 18, 120, 122, 233 💬
547Deferiprone (Ferriprox)1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
548Deferiprone 20mg1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
549Deferiprone 30mg1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
550Deferiprone 600 mg delayed release tablet1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
551Deferiprone DR1件: Deferiprone1件: Deferiprone 💬 --2件: 2, 6 💬
552Desmopressin1件: Desmopressin1件: Desmopressin 💬 2件: AVPR2,
F8 💬 		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬5件: 6, 64, 72, 225, 288 💬
553Desmopressin Acetat1件: Desmopressin1件: Desmopressin 💬 2件: AVPR2,
F8 💬 		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 6 💬
554Desmotabs----1件: 6 💬
555Desmotabs® 0,2 mg Tabletten----1件: 6 💬
556Desmotabs® 0,2mg Tabletten----1件: 6 💬
557Determination of drug effects through amantadine cessation1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
558Dexdor1件: Dexmedetomidine1件: Dexmedetomidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬4件: 2, 4, 6, 70 💬
559DEXMEDETOMIDINA1件: Dexmedetomidine1件: Dexmedetomidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
560DEXMEDETOMIDINE1件: Dexmedetomidine1件: Dexmedetomidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
561Dexmedetomidine Hydrochloride Infusion1件: Dexmedetomidine1件: Dexmedetomidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
562Dextromethorphan1件: Dextromethorphan1件: Dextromethorphan 💬 6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬
563DHA----8件: 6, 46, 48, 49, 94, 113, 299, 301 💬
564Different diets----1件: 6 💬
565Dihydroergotoxine1件: Dihydroergotoxine1件: Dihydroergotoxine 💬 --1件: 6 💬
566Dihydroergotoxine Mesylate2件: Dihydroergotoxine,
Ergoloid mesylate		1件: Dihydroergotoxine 💬 --1件: 6 💬
567Dipivefrin1件: Dipivefrin1件: Dipivefrin 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
568Dipivefrine1件: Dipivefrin1件: Dipivefrin 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
569Dipraglurant1件: Dipraglurant---1件: 6 💬
570Ditropan elixir1件: Oxybutynin1件: Oxybutynin 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
571DM----2件: 6, 8 💬
572DM-1992----1件: 6 💬
573DNA/GeneticTesting----1件: 6 💬
574DNL151----1件: 6 💬
575DNL151, DN0001575, DN1575----1件: 6 💬
576DNL201----1件: 6 💬
577DNS-7801 (high dose)----1件: 6 💬
578DNS-7801 (low-dose)----1件: 6 💬
579Docosahexaenoic acid1件: Doconexent---7件: 6, 49, 90, 94, 240, 299, 301 💬
580Docosahexaenoic Acid (DHA)1件: Doconexent---3件: 6, 94, 299 💬
581Domperidone1件: Domperidone2件: Domperidone ,
Domperidone maleate 💬 		1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬5件: 6, 13, 17, 51, 230 💬
582Domperidone (drug)1件: Domperidone2件: Domperidone ,
Domperidone maleate 💬 		1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
583Dompéridone----1件: 6 💬
584Donepezil1件: Donepezil1件: Donepezil 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬9件: 5, 6, 13, 46, 78, 124, 127, 156, 206 💬
585Donepezil Hydrochloride1件: Donepezil1件: Donepezil 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬3件: 6, 124, 156 💬
586Donepezil Sandoz1件: Donepezil1件: Donepezil 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
587DopaFuse Delivery System----1件: 6 💬
588Dopamine1件: Dopamine1件: Dopamine 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 7, 74 💬
589Dopamine Agent1件: Dopamine1件: Dopamine 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
590Dopamine Agonists (pramipexole, ropirinole)2件: Dopamine,
Pramipexole		2件: Pramipexole ,
Dopamine 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
591Dopaminergic Agonist + Apomorphine1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
592Dopaminergic Agonists----1件: 6 💬
593DOPS1件: Droxidopa1件: Droxidopa 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 17 💬
594Doxepin1件: Doxepin1件: Doxepin 💬 3件: HRH1,
SLC6A2,
SLC6A4 💬 		5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
595Doxepin and Zopiclone2件: Doxepin,
Zopiclone		2件: Zopiclone ,
Doxepin 💬 		19件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
HRH1,
SLC6A2,
SLC6A4 💬 		10件: Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 💬1件: 6 💬
596DPA----5件: 2, 6, 13, 85, 127 💬
597DPA-714-PET/MRI----1件: 6 💬
598Droxidopa1件: Droxidopa1件: Droxidopa 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 5, 6, 17, 169, 170 💬
599Droxidopa 100 MG [Northera]1件: Droxidopa1件: Droxidopa 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
600Duloxetine1件: Duloxetine1件: Duloxetine 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 13 💬
601Duloxetine hydrochloride1件: Duloxetine1件: Duloxetine 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
602DUODOPA2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
603Duodopa gel intestinale2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
604Duodopa intestinal gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
605Duodopa intestinalgel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
606Duodopa LD/CD 20/5 mg/mL2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
607Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
608Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
609DUODOPA®Intestinal Gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
610Dynacirc CR (Isradipine)1件: Isradipine1件: Isradipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
611E2007----2件: 6, 144 💬
612E2027----1件: 6 💬
613EBIXA1件: Memantine1件: Memantine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬3件: 2, 6, 13 💬
614EBIXA®----1件: 6 💬
615EDARAVONE1件: Edaravone1件: Edaravone 💬 --3件: 2, 6, 22 💬
616EGCG1件: Epigallocatechin gallate---9件: 6, 8, 13, 17, 28, 85, 113, 206, 299 💬
617ELC200----1件: 6 💬
618Eliprodil1件: Eliprodil---1件: 6 💬
619Elobixibat1件: Elobixibat1件: Elobixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 6 💬
620ELTOPRAZINE1件: Eltoprazine---1件: 6 💬
621Eltoprazine HCl1件: Eltoprazine---1件: 6 💬
622Eltoprazine Hydrochloride1件: Eltoprazine---1件: 6 💬
623EMD 128130----2件: 6, 156 💬
624EMD128130----1件: 6 💬
625EN----3件: 6, 46, 97 💬
626ENA713----2件: 6, 13 💬
627ENA713B----1件: 6 💬
628ENT-01----1件: 6 💬
629Entacapon----1件: 6 💬
630ENTACAPONA1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
631ENTACAPONE1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬2件: 6, 17 💬
632Entacapone 400mg oral dose1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬2件: 6, 17 💬
633Entacapone and carbidopa2件: Carbidopa,
Entacapone		2件: Carbidopa ,
Entacapone 💬 		2件: COMT,
DDC 💬 		10件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
634ENTACAPONE INN1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
635Entecapone----1件: 6 💬
636EPI-5891件: EPI-589---2件: 2, 6 💬
637EPI-743 200mg----1件: 6 💬
638EPI-743 400mg----1件: 6 💬
639Equal----4件: 6, 13, 67, 86 💬
640Equfina----1件: 6 💬
641Equfina 50 mg----1件: 6 💬
642ER CD-LD----1件: 6 💬
643ER tablet 100 mg AZD3241----1件: 6 💬
644ER tablet 25 mg AZD3241----1件: 6 💬
645Eradication of Helcobacter Pylori----1件: 6 💬
646Eradication therapy for H.pylori infection----1件: 6 💬
647Eradication therapy for Helicobacter pylori----1件: 6 💬
648Erythromycin1件: Erythromycin1件: Erythromycin 💬 --5件: 6, 36, 164, 228, 291 💬
649ERYTHROPOIETIN1件: Erythropoietin---9件: 2, 6, 13, 18, 22, 47, 70, 95, 96 💬
650Erythropoietin human recombinant (EPOrh)1件: Erythropoietin---1件: 6 💬
651Escitalopram1件: Escitalopram1件: Escitalopram 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 2, 6, 13, 46 💬
652Escitalopram oxalate1件: Escitalopram1件: Escitalopram 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
653Eszopiclone1件: Eszopiclone1件: Eszopiclone 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬3件: 6, 13, 46 💬
654ETHNODYNE VISIO----1件: 6 💬
655Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester (**See other 2 names below)----1件: 6 💬
656Etomidate1件: Etomidate1件: Etomidate 💬 1件: GABRA1 💬 6件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬1件: 6 💬
657Exametazime1件: Exametazime1件: Exametazime 💬 --1件: 6 💬
658EXELON1件: Rivastigmine1件: Rivastigmine 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬2件: 6, 13 💬
659Exelon 4.6 mg/24 h transdermal patch1件: Rivastigmine1件: Rivastigmine 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
660Exelon 9.5 mg/24 h transdermal patch1件: Rivastigmine1件: Rivastigmine 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
661Exelon Patch1件: Rivastigmine1件: Rivastigmine 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
662Exelon Patch (rivastigmine transdermal system)1件: Rivastigmine1件: Rivastigmine 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
663Exelon path transdermal1件: Rivastigmine1件: Rivastigmine 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
664Exelon ®1件: Rivastigmine1件: Rivastigmine 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
665EXENATIDE1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 6, 17, 72, 78, 193, 233 💬
666Exenatide 10 micrograms1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
667Exenatide 5 micrograms1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
668Exenatide extended release 2mg (Bydureon)1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
669EXN-32----1件: 6 💬
670EXN-32 (CARBIDOPA E LEVODOPA)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
671EXN-44----1件: 6 💬
672EXN-44(LEVODOPA)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
673Extended Release Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
674F-18 FPCIT----1件: 6 💬
675Famotidine1件: Famotidine1件: Famotidine 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬5件: 6, 46, 86, 98, 107 💬
676FB-101----1件: 6 💬
677Febuxostat1件: Febuxostat1件: Febuxostat 💬 1件: XDH 💬 6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬3件: 2, 6, 13 💬
678Ferriprox1件: Deferiprone1件: Deferiprone 💬 --2件: 6, 120 💬
679Ferriprox 500 mg1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
680Ferrprox (Deferiprone)1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
681Fesoterodine1件: Fesoterodine1件: Fesoterodine 💬 2件: CHRM2,
CHRM3 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
682Fetal porcine cells, Neurocell-PD----1件: 6 💬
683Filgrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
684Finamine tablets----1件: 6 💬
685Finasteride1件: Finasteride1件: Finasteride 💬 1件: SRD5A2 💬 3件: Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬1件: 6 💬
686Fipamezole1件: Fipamezole---2件: 6, 17 💬
687Fipamezole hydrochloride1件: Fipamezole---2件: 6, 17 💬
688Fipamezole hydrochloride 30 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
689Fipamezole hydrochloride 60 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
690Fipamezole hydrochloride 90 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
691Fipamezole ODT1件: Fipamezole---1件: 6 💬
692Fipamezole ODT Cohort 21件: Fipamezole---1件: 6 💬
693Flecainide1件: Flecainide1件: Flecainide 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
694FLECAINIDE ACETATE2件: Acetate,
Flecainide		1件: Flecainide 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
695Flecainidum1件: Flecainide1件: Flecainide 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
696FLORBETABEN (18F)----1件: 6 💬
697Florbetapir F 18----1件: 6 💬
698Fludrocortisone1件: Fludrocortisone1件: Fludrocortisone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬3件: 6, 17, 81 💬
699Flumazenil1件: Flumazenil1件: Flumazenil 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206 💬
700Flutemetamol1件: Flutemetamol---4件: 5, 6, 7, 127 💬
701Folic acid1件: Folic acid1件: Folic acid 💬 --5件: 6, 46, 49, 84, 296 💬
702Folic Acid, Vitamin B6, Vitamin B123件: Cyanocobalamin,
Folic acid,
Pyridoxine		6件: Folic acid ,
Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 ,
Pyridoxine 💬 		--1件: 6 💬
703Foliglurax1件: Foliglurax---1件: 6 💬
704Foliglurax 10 mg (treatment A)1件: Foliglurax---1件: 6 💬
705Foliglurax 30 mg (treatment B)1件: Foliglurax---1件: 6 💬
706Fortiral----1件: 6 💬
707Foscarbidopa1件: Foscarbidopa1件: Foscarbidopa 💬 --1件: 6 💬
708Foscarbidopa and Foslevodopa2件: Foscarbidopa,
Foslevodopa		2件: Foslevodopa ,
Foscarbidopa 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
709Foslevodopa1件: Foslevodopa1件: Foslevodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
710FPF1100NW----1件: 6 💬
711FPFS-1169----1件: 6 💬
712Furosemide1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬2件: 6, 86 💬
713Furosemide Injection1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6 💬
714G-CSF1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬16件: 2, 6, 11, 13, 16, 22, 47, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬
715G2019S LRRK2----1件: 6 💬
716GABAPENTIN1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬5件: 6, 13, 19, 70, 298 💬
717GABAPENTINA1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 6 💬
718GABAPENTINA KERN PHARMA1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 6 💬
719GALANTAMINE1件: Galantamine1件: Galantamine 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬2件: 6, 127 💬
720Galantamine hydrobromide1件: Galantamine1件: Galantamine 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬2件: 6, 127 💬
721Ganoderma----1件: 6 💬
722GE180 PET Scan----1件: 6 💬
723General anesthesia----1件: 6 💬
724Genetic testing----3件: 6, 90, 299 💬
725GENZ-6824521件: Venglustat1件: Venglustat 💬 1件: UGCG 💬 2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 6, 19, 67 💬
726Genz-682452-AU1件: Venglustat1件: Venglustat 💬 1件: UGCG 💬 2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 6, 19, 67 💬
727Ghrelin1件: Lenomorelin---6件: 6, 78, 193, 201, 202, 299 💬
728Ginkgo1件: Ginkgo biloba---5件: 6, 13, 18, 47, 90 💬
729Glial cell line-derived neurotrophic factor----1件: 6 💬
730Glial Cell Line-Derived Neurotrophic Factor (GDNF)----1件: 6 💬
731Glucose2件: D-glucose,
Dextrose, unspecified form		1件: Glucose 💬 --12件: 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299 💬
732Glutathione1件: Glutathione2件: Glutathione ,
Oxiglutatione 💬 		--2件: 6, 299 💬
733Glycerol1件: Glycerin1件: Glycerin 💬 --5件: 6, 13, 79, 316, 317 💬
734Glycerol Phenylbutyrate3件: Glycerin,
Glycerol phenylbutyrate,
Phenylbutyric acid		2件: Glycerin ,
Glycerol phenylbutyrate 💬 		--1件: 6 💬
735Glycopyrrolate----2件: 6, 34 💬
736GM1 ganglioside----1件: 6 💬
737GM6081件: Alirinetide---1件: 6 💬
738GOCOVRI----1件: 6 💬
739Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 💬
740Gold Nanocrystals1件: Gold---3件: 2, 6, 13 💬
741GPI 1485----1件: 6 💬
742Grapefruit1件: Grapefruit---5件: 6, 46, 50, 83, 97 💬
743Green Tea1件: Green tea leaf1件: Green tea leaf 💬 --4件: 6, 17, 28, 46 💬
744Green Tea Polyphenols (EGCG/ECG)2件: Epigallocatechin gallate,
Green tea leaf		1件: Green tea leaf 💬 --1件: 6 💬
745GRF6021----1件: 6 💬
746Group AD Anti-PD + Antidepressant----1件: 6 💬
747Group R Rasagiline1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
748Group R+AD Rasagiline + Antidepressant1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
749GSH----2件: 6, 299 💬
750GSK962040----1件: 6 💬
751GSK962040 (25 mg tablet)----1件: 6 💬
752Guar gum1件: Guar gum1件: Guar gum 💬 --1件: 6 💬
753HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM----2件: 6, 49 💬
754HAESCs----1件: 6 💬
755HAESCs treatment----1件: 6 💬
756HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---5件: 2, 6, 13, 14, 46 💬
757Healthy----1件: 6 💬
758HEC122505MsOH----1件: 6 💬
759Helicobacter pylori eradication therapy----1件: 6 💬
760Heptaminol1件: Heptaminol1件: Heptaminol 💬 --1件: 6 💬
761Heptaminol hydrochloride1件: Heptaminol1件: Heptaminol 💬 --1件: 6 💬
762Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)1件: Reynoutria multiflora root---1件: 6 💬
763Hericium erinaceus mycelium----1件: 6 💬
764Heshouwu1件: Reynoutria multiflora root---1件: 6 💬
765HF0220----1件: 6 💬
766High dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
767High dose ANAVEX2-73----1件: 6 💬
768High dose levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
769High Fiber supplement----1件: 6 💬
770High Protein. T-Diet plus Range----1件: 6 💬
771HNC364----1件: 6 💬
772HP-3000 (ropinirole hydrochloride patch)1件: Ropinirole1件: Ropinirole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
773HP-3000 placebo----1件: 6 💬
774HP-3000(ropinirole hydrochloride patch)1件: Ropinirole1件: Ropinirole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
775Human neural stem cell----1件: 6 💬
776Human Stem Cells----1件: 6 💬
777Hydrocortisone2件: Hydrocortisone,
Hydrocortisone acetate		2件: Hydrocortisone ,
Hydrocortisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬10件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
778Hydrocortisone cream1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
779Hydrocortisone cream 1%1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
780Hydrocortisone cream 10mg/g FNA Fagron1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
781Hydrogen1件: Hydrogen---6件: 5, 6, 17, 83, 97, 226 💬
782Hydrolyzed guar gum1件: Guar gum1件: Guar gum 💬 --1件: 6 💬
783Hypoestoxide----1件: 6 💬
784Hypoxic Gas Mixture----1件: 6 💬
785I 1231件: Iodide I-123---1件: 6 💬
786I-1231件: Iodide I-123---2件: 2, 6 💬
787I-123-5-IA853801件: Iodide I-123---1件: 6 💬
788IBEROGAST----1件: 6 💬
789Idebenone1件: Idebenone1件: Idebenone 💬 --6件: 6, 8, 13, 18, 113, 302 💬
790Identification of COMT HH, COMT HL or COMT LL genes----1件: 6 💬
791IkT-148009----1件: 6 💬
792Iloperidone1件: Iloperidone1件: Iloperidone 💬 4件: DRD2,
HTR2A,
HTR2B,
HTR2C 💬 		11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬1件: 6 💬
793Immediate release carbidopa/levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
794Immediate Release carbidopa/levodopa 10/100 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
795Immediate Release carbidopa/levodopa 25/100 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
796Immediate Release Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
797Inbrija----1件: 6 💬
798Incobotulinum Toxin A----3件: 2, 6, 13 💬
799IncobotulinumtoxinA1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
800IncobotulinumtoxinA (100 Units)1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
801IncobotulinumtoxinA (75 Units)1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
802Infudopa i.v.----1件: 6 💬
803Infudopa s.c.----1件: 6 💬
804Infusions of young plasma----1件: 6 💬
805Inhaled VR040----1件: 6 💬
806Injection of apomorphine1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
807Injection of normal saline----1件: 6 💬
808Injection of Umbilical cord derived MSCs----1件: 6 💬
809Inosine1件: Inosine1件: Inosine 💬 --5件: 2, 6, 13, 17, 122 💬
810INS-GSH----1件: 6 💬
811Insulin----6件: 6, 13, 46, 75, 78, 299 💬
812Intracerebral microinjections----1件: 6 💬
813Intranasal glutathione - (in)GSH1件: Glutathione2件: Glutathione ,
Oxiglutatione 💬 		--1件: 6 💬
814Intranasal Insulin----2件: 6, 17 💬
815Intravenous Infusion----2件: 6, 51 💬
816Intravenous Levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
817Intravesical injection of Botulinum A toxin----2件: 6, 17 💬
818Inulin1件: Inulin1件: Inulin 💬 --4件: 6, 96, 156, 299 💬
819IODIO IOFLUPANO-123I----1件: 6 💬
820Ioflupane----1件: 6 💬
821IOFLUPANE (123I)----1件: 6 💬
822Ioflupane 123I (DATSCAN®)1件: Ioflupane I-123---1件: 6 💬
823Ioflupane [123 I]----1件: 6 💬
824Ioflupane [123I]----1件: 6 💬
825Ioflupane I 1232件: Iodide I-123,
Ioflupane I-123		---1件: 6 💬
826Ipratropium1件: Ipratropium---2件: 6, 86 💬
827Ipratropium bromide (drug)1件: Ipratropium---1件: 6 💬
828IPRONIAZID1件: Iproniazid1件: Iproniazid 💬 2件: MAOA,
MAOB 💬 		14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
829Ips-nsc cells----1件: 6 💬
830IPT803----1件: 6 💬
831IPX054 100 mg----1件: 6 💬
832IPX054 150 mg----1件: 6 💬
833IPX054 200 mg----1件: 6 💬
834IPX054 250 mg----1件: 6 💬
835IPX054 300 mg----1件: 6 💬
836IPX066----1件: 6 💬
837IPX066 145 mg----1件: 6 💬
838IPX066 145 mg LD----1件: 6 💬
839IPX066 195 mg----1件: 6 💬
840IPX066 195 mg LD----1件: 6 💬
841IPX066 245 mg----1件: 6 💬
842IPX066 245 mg LD----1件: 6 💬
843IPX066 95 mg----1件: 6 💬
844IPX066 95 mg LD----1件: 6 💬
845IPX066-145----1件: 6 💬
846IPX066-195----1件: 6 💬
847IPX066-245----1件: 6 💬
848IPX066-95----1件: 6 💬
849IPX203----1件: 6 💬
850IPX203 140 mg----1件: 6 💬
851IPX203 180 mg----1件: 6 💬
852IPX203 210 mg----1件: 6 💬
853IPX203 270 mg----1件: 6 💬
854IPX203 280 mg----1件: 6 💬
855IPX203 350 mg----1件: 6 💬
856IPX203 ER CD-LD----1件: 6 💬
857IR CD-LD----1件: 6 💬
858IR CD-LD (carbidopa-levodopa) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
859IR LD / CD----1件: 6 💬
860IR LD/CD----1件: 6 💬
861IRL752----1件: 6 💬
862IRL790----1件: 6 💬
863IRX4204----1件: 6 💬
864ISC-hpNSC----1件: 6 💬
865Isicom----1件: 6 💬
866Isoflurane1件: Isoflurane1件: Isoflurane 💬 --1件: 6 💬
867Isradipine1件: Isradipine1件: Isradipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
868Isradipine CR 10mg1件: Isradipine1件: Isradipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
869Isradipine CR 20mg1件: Isradipine1件: Isradipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
870Isradipine CR 5mg1件: Isradipine1件: Isradipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
871ISTRADEFYLLINE1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
872Istradefylline ( KW-6002)1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
873Istradefylline (KW-6002)1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
874Istradefylline 20 mg1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
875Istradefylline 20 mg or 40 mg1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
876Istradefylline 40 mg1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
877ITI-2141件: ITI-214---1件: 6 💬
878IV Apomorphine1件: Apomorphine1件: Apomorphine 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
879IV Levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
880IZD174----2件: 6, 106 💬
881JM----2件: 6, 13 💬
882JM-010----1件: 6 💬
883JNJ-31001074----1件: 6 💬
884JNJ31-31001074----1件: 6 💬
885JP 1730----1件: 6 💬
886JP-1730/F01----2件: 6, 17 💬
887JP-1730/F02----2件: 6, 17 💬
888JP-1730/F03----2件: 6, 17 💬
889Juvit D3----1件: 6 💬
890JZP-110----1件: 6 💬
891K0706----1件: 6 💬
892KDT-35941件: KDT-3594---1件: 6 💬
893KETAMINE1件: Ketamine1件: Ketamine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬6件: 6, 13, 70, 113, 156, 215 💬
894Ketamine Infusion1件: Ketamine1件: Ketamine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
895Ketone ester drink----1件: 6 💬
896Ketone Ester Elite endurance Nutrition Drink----1件: 6 💬
897Kinoquinone (proposed)----1件: 6 💬
898KM-819----2件: 6, 17 💬
899KW-6002----1件: 6 💬
900KW-6002 (istradefylline)1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
901KW-63561件: KW-6356---1件: 6 💬
902KW-6356 High Dose1件: KW-6356---1件: 6 💬
903KW-6356 Low Dose1件: KW-6356---1件: 6 💬
904KW-6356 Middle Dose1件: KW-6356---1件: 6 💬
905KW-6356 X Dose1件: KW-6356---1件: 6 💬
906KW-6356 Y Dose1件: KW-6356---1件: 6 💬
907KW-6500----1件: 6 💬
908L-123 Ioflupane----1件: 6 💬
909L-3-(3,4-Dihydroxyphenyl)alanine1件: Alanine1件: Alanine 💬 --1件: 6 💬
910L-DOPA1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
911L-Dopa/ MODOPAR1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
912L-DOPA/DDCI1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
913L-DOPS1件: Droxidopa1件: Droxidopa 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
914L-methylfolate1件: Levomefolic acid1件: Levomefolic acid 💬 --1件: 6 💬
915L-tyrosine1件: Tyrosine1件: Tyrosine 💬 --2件: 6, 111 💬
916LA----5件: 6, 13, 76, 78, 256 💬
917Lactobacillus1件: Lactobacillus delbrueckii bulgaricus---5件: 6, 46, 51, 97, 299 💬
918Lactobacillus acidophilus1件: Lactobacillus acidophilus1件: Lactomin 💬 --1件: 6 💬
919Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers1件: Lactobacillus acidophilus1件: Lactomin 💬 --1件: 6 💬
920Lactobacillus casei1件: Lactobacillus casei1件: Lactobacillus casei 💬 --3件: 6, 97, 296 💬
921Lactobacillus casei DG (Enterolactis duo®)1件: Lactobacillus casei1件: Lactobacillus casei 💬 --1件: 6 💬
922Lactobacillus plantarum1件: Lactobacillus plantarum---3件: 6, 97, 156 💬
923Lactobacillus plantarum PS1281件: Lactobacillus plantarum---1件: 6 💬
924Lactose1件: Lactose2件: Anhydrous lactose ,
Lactose 💬 		--6件: 2, 6, 13, 97, 228, 310 💬
925LCIG----1件: 6 💬
926LCIG (Duodopa)----1件: 6 💬
927LD / BE----1件: 6 💬
928LD/CD----1件: 6 💬
929Lenrispodun----1件: 6 💬
930Leptin1件: Leptin---2件: 6, 265 💬
931Leucine1件: Leucine1件: Leucine 💬 --6件: 6, 19, 65, 283, 284, 299 💬
932Levetiracetam1件: Levetiracetam1件: Levetiracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬5件: 2, 4, 6, 13, 307 💬
933LEVODOPA1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬6件: 6, 17, 90, 140, 164, 201 💬
934LEVODOPA (DC.IT) (FU)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
935Levodopa (delivered intravenously)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
936Levodopa (drug), intraduodenal administration1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
937Levodopa (L-dopa)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
938Levodopa (L-DOPA) + Standard care1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
939LEVODOPA (LD)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
940Levodopa / Benserazid1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
941LEVODOPA / BENSERAZIDE 200 + 50 MG2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
942Levodopa / carbidopa solution2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
943Levodopa 100 mg / benserazide 25 mg2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
944Levodopa 100 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
945Levodopa 125 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
946Levodopa 150 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
947Levodopa 25mg/100mg1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
948Levodopa 75 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
949Levodopa acute challenge1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
950Levodopa and carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
951Levodopa and carbidopa SC solution2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
952Levodopa and carbidopa solution for SC administration2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
953Levodopa and decarboxylase inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
954Levodopa and Domperidone2件: Domperidone,
Levodopa		3件: Levodopa ,
Domperidone ,
Domperidone maleate 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
955Levodopa Benserazide Madopar2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
956Levodopa Benserazide Teva Italia2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
957Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
958Levodopa carbidopa intestinal gel (LCIG)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
959Levodopa CR (controlled release)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
960Levodopa Cyclops1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
961LEVODOPA DC.IT FU1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
962Levodopa dispersible1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
963Levodopa infusion1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
964LEVODOPA INN1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
965Levodopa MR1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
966Levodopa powder for inhalation1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
967Levodopa, carbidopa, entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
968Levodopa, carbidopa, ODM-1042件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
969Levodopa, decarboxylase inhibitor and COMT inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
970Levodopa-4'-Monophosphate2件: Foslevodopa,
Levodopa		2件: Levodopa ,
Foslevodopa 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
971Levodopa-Carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬2件: 6, 90 💬
972Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
973Levodopa-carbidopa Immediate Release (LC-IR) Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
974Levodopa-Carbidopa Intestinal Gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
975Levodopa-Carbidopa Intestinal Gel (LCIG)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
976Levodopa-Carbidopa Multilayer Extended Release Tablet2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
977Levodopa-Carbidopa XL tablet (M)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
978Levodopa-carbidopa-entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
979Levodopa/benserazide2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
980Levodopa/benserazide 100/25 mg2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
981LEVODOPA/BENZERASIDE1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
982Levodopa/Benzerazide1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
983LEVODOPA/CARBIDOPA2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬2件: 6, 164 💬
984Levodopa/Carbidopa (LD/CD)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
985Levodopa/Carbidopa (Sinemet)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
986Levodopa/carbidopa 100/252件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
987Levodopa/Carbidopa Hydrate2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
988Levodopa/Carbidopa Solution2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
989Levodopa/Carbidopa(200mg/50mg)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
990Levodopa/carbidopa/entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
991Levodopa/DDCI1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
992Levodopa/dopa decarboxylase inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
993Liatermin1件: Liatermin1件: Liatermin 💬 --1件: 6 💬
994Liatermin (r-metHuGDNF)1件: Liatermin1件: Liatermin 💬 --1件: 6 💬
995Lidocaine1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬12件: 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 256 💬
996Linaclotide1件: Linaclotide1件: Linaclotide 💬 1件: GUCY2C 💬 2件: Metabolic pathways, Purine metabolism 💬2件: 6, 97 💬
997Lingzhi (Ganoderma)----1件: 6 💬
998Lipuro----1件: 6 💬
999Liquigen MCT oil----1件: 6 💬
1000Liraglutide1件: Liraglutide1件: Liraglutide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 6, 75, 193 💬
1001Lisparin----1件: 6 💬
1002LISURIDE1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 86 💬
1003Lisuride Hydrogenmaleate1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1004Lisuride Transdermal System1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1005Lisuride TTS1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1006Lisuride TTS 10cm²1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1007Lisuride TTS 20cm²1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1008Lithium2件: Lithium carbonate,
Lithium citrate		2件: Lithium carbonate ,
Lithium citrate 💬 		--5件: 2, 5, 6, 7, 8 💬
1009Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules1件: Lactobacillus delbrueckii bulgaricus---1件: 6 💬
1010Lixisenatide1件: Lixisenatide1件: Lixisenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
1011Local Anesthesia (lidocaine hydrochloride)1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
1012Local Trade Name, 2mg----1件: 6 💬
1013Local Trade Name, 4mg----1件: 6 💬
1014Local Trade Name, 8mg----1件: 6 💬
1015LODALÈS®----1件: 6 💬
1016Lovastatin1件: Lovastatin1件: Lovastatin 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
1017Low dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
1018Low dose levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1019Lu 00-800----1件: 6 💬
1020Lu AF28996----1件: 6 💬
1021Lu AF82422----2件: 6, 17 💬
1022LUBIPROSTONE1件: Lubiprostone1件: Lubiprostone 💬 1件: CLCN2 💬 1件: Mineral absorption 💬4件: 6, 13, 290, 299 💬
1023LY03003----1件: 6 💬
1024LY03003 ( Rotigotine, extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1025LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1026LY03003( the name of rotigotine)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1027LY03003(Rotigotine,extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1028LY03009 F1----1件: 6 💬
1029LY03009 F2----1件: 6 💬
1030LY03009 F3----1件: 6 💬
1031LY03009 F4----1件: 6 💬
1032LY300164----1件: 6 💬
1033LY3154207----1件: 6 💬
1034Madopar----1件: 6 💬
1035Madopar 125 mg T, tablets----1件: 6 💬
1036Madopar 125 mg, orodispersible tablet----1件: 6 💬
1037Madopar 200+50 mg----1件: 6 💬
1038Madopar LT----1件: 6 💬
1039Madopar monotherapy----1件: 6 💬
1040Madopar Tab. 125 or Perkin Tab. 25-100mg----1件: 6 💬
1041Madopar® 125----1件: 6 💬
1042Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride)2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1043Madopar® 250----1件: 6 💬
1044Madopar® HBS----1件: 6 💬
1045Madopar® HBS 125----1件: 6 💬
1046Magnesium1件: Magnesium---15件: 6, 11, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬
1047Magnesium oxide2件: Magnesium,
Magnesium oxide		1件: Magnesium oxide 💬 --3件: 6, 166, 291 💬
1048Maltodextrin1件: Maltodextrin1件: Maltodextrin 💬 --4件: 6, 13, 96, 97 💬
1049Mannitol1件: Mannitol1件: Mannitol 💬 --7件: 6, 13, 28, 60, 96, 113, 299 💬
1050MANTADIX----1件: 6 💬
1051MARS----1件: 6 💬
1052MASITINIB1件: Masitinib1件: Masitinib 💬 1件: KIT 💬 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬6件: 2, 5, 6, 13, 46, 96 💬
1053MASITINIB MESYLATE1件: Masitinib1件: Masitinib 💬 1件: KIT 💬 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬6件: 2, 5, 6, 13, 46, 96 💬
1054Mavoglurant1件: Mavoglurant---2件: 6, 206 💬
1055MC1----1件: 6 💬
1056MCT----2件: 6, 296 💬
1057ME2125 (safinamide mesilate)1件: Safinamide1件: Safinamide 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1058MEDI1341----1件: 6 💬
1059Medical Cannabis1件: Medical Cannabis---3件: 6, 96, 97 💬
1060Mediterranean diet supplemented with medium-chain triglyceride oil----1件: 6 💬
1061Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬12件: 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬
1062Melatonin PR1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
1063Melatonin(Circadin®)1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
1064Melevodopa1件: Melevodopa1件: Melevodopa 💬 --1件: 6 💬
1065Melevodopa and decarboxylase inhibitor1件: Melevodopa1件: Melevodopa 💬 --1件: 6 💬
1066Melperon----1件: 6 💬
1067Melperone1件: Melperone1件: Melperone 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1068Melperone HCl1件: Melperone1件: Melperone 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1069Memantin Orion----1件: 6 💬
1070Memantine1件: Memantine1件: Memantine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬8件: 2, 6, 8, 13, 49, 127, 205, 206 💬
1071Memantine (drug)1件: Memantine1件: Memantine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
1072MEMANTINE HYDROCHLORIDE1件: Memantine1件: Memantine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬3件: 2, 6, 127 💬
1073Mesdopetam1件: Mesdopetam---1件: 6 💬
1074Mesdopetam (IRL790)1件: Mesdopetam---1件: 6 💬
1075Mesencephalic Neuronal Precursor Cells----1件: 6 💬
1076Mesenchymal stem cells----11件: 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299 💬
1077Mestinon1件: Pyridostigmine---3件: 3, 6, 11 💬
1078Metformin1件: Metformin1件: Metformin 💬 2件: PRKAA1,
PRKAA2 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 💬
1079Methylphenidate1件: Methylphenidate1件: Methylphenidate 💬 2件: SLC6A2,
SLC6A3 💬 		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 6, 13, 34, 84, 113, 179, 206 💬
1080Methylphenidate (MPD)1件: Methylphenidate1件: Methylphenidate 💬 2件: SLC6A2,
SLC6A3 💬 		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 6 💬
1081METHYLPHENIDATE HYDROCHLORIDE1件: Methylphenidate1件: Methylphenidate 💬 2件: SLC6A2,
SLC6A3 💬 		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 6, 13 💬
1082Mg----5件: 6, 13, 51, 63, 111 💬
1083Mg++----1件: 6 💬
1084Mid dose ANAVEX2-73----1件: 6 💬
1085Midazolam1件: Midazolam1件: Midazolam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬
1086Midodrine1件: Midodrine1件: Midodrine 💬 3件: ADRA1A,
ADRA1B,
ADRA1D 💬 		7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬3件: 6, 17, 58 💬
1087Minocycline1件: Minocycline1件: Minocycline 💬 --13件: 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬
1088Minodronic acid1件: Minodronic acid---4件: 6, 46, 93, 95 💬
1089Mirabegron1件: Mirabegron1件: Mirabegron 💬 1件: ADRB3 💬 8件: Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬4件: 6, 13, 53, 226 💬
1090Mirapex1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1091Mirapex (pramipexole)1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1092Mirapex ER----1件: 6 💬
1093Mirapex LA----1件: 6 💬
1094Mirapexin1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1095Mirapexin / Sifrol1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1096Mirapexin extended release various strengths2件: Manganese citrate,
Pramipexole		1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1097MIRAPEXIN*30CPR 0,7MG1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1098Mirapexin/Sifrol1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1099MitoQ----3件: 6, 13, 97 💬
1100MK0657----1件: 6 💬
1101MOCLOBEMIDE1件: Moclobemide1件: Moclobemide 💬 1件: MAOA 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1102MODAFINIL1件: Modafinil1件: Modafinil 💬 --4件: 6, 13, 49, 93 💬
1103Modafinil 50mg1件: Modafinil1件: Modafinil 💬 --1件: 6 💬
1104Modal----2件: 6, 70 💬
1105Modiodal----1件: 6 💬
1106MODOPAR----1件: 6 💬
1107Modopar 125----1件: 6 💬
1108Modopar 62,5----1件: 6 💬
1109Monoamine oxidase B inhibitors----1件: 6 💬
1110Montelukast1件: Montelukast1件: Montelukast 💬 1件: CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬8件: 6, 13, 46, 61, 63, 85, 98, 228 💬
1111Montelukast Krka1件: Montelukast1件: Montelukast 💬 1件: CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 6 💬
1112MOTILIUM----2件: 6, 230 💬
1113Moxifloxacin1件: Moxifloxacin1件: Moxifloxacin 💬 --9件: 2, 6, 46, 49, 85, 86, 113, 240, 299 💬
1114Moxifloxacin infusion1件: Moxifloxacin1件: Moxifloxacin 💬 --1件: 6 💬
1115MSC----6件: 6, 51, 60, 96, 97, 271 💬
1116MSK-DA01----1件: 6 💬
1117Multi-strain probiotic----1件: 6 💬
1118Muscimol1件: Muscimol---1件: 6 💬
1119Mushroom1件: Cultivated mushroom---2件: 6, 46 💬
1120Mémantine----1件: 6 💬
1121N-0923----1件: 6 💬
1122N-Acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬 --13件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 299, 337 💬
1123N-acetylcysteine capsule1件: Acetylcysteine1件: Acetylcysteine 💬 --1件: 6 💬
1124N.a.----10件: 3, 6, 8, 13, 46, 96, 97, 240, 256, 271 💬
1125N04BA----1件: 6 💬
1126N04BC07----1件: 6 💬
1127N04BD02----1件: 6 💬
1128NABILONE1件: Nabilone1件: Nabilone 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬3件: 6, 13, 127 💬
1129Nabilone 0.25 mg1件: Nabilone1件: Nabilone 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
1130Nacom----1件: 6 💬
1131NACOM 100----1件: 6 💬
1132NACOM levodopa+cardidopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1133Nadolol1件: Nadolol1件: Nadolol 💬 2件: ADRB1,
ADRB2 💬 		11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1134NAL----2件: 6, 299 💬
1135Nalmefene1件: Nalmefene1件: Nalmefene 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1136Naloxone1件: Naloxone1件: Naloxone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 226 💬
1137NALOXONE HYDROCHLORIDE DIHYDRATE1件: Naloxone1件: Naloxone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1138Naltrexone1件: Naltrexone1件: Naltrexone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬12件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
1139Nardil1件: Phenelzine1件: Phenelzine 💬 2件: MAOA,
MAOB 💬 		14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1140NBTX-001----1件: 6 💬
1141Nd----6件: 2, 6, 13, 46, 51, 97 💬
1142ND0611----1件: 6 💬
1143ND0612----1件: 6 💬
1144ND0612 (Levodopa/Carbidopa solution)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1145ND1421----1件: 6 💬
1146ND1587----1件: 6 💬
1147ND1589----1件: 6 💬
1148ND1590----1件: 6 💬
1149ND1702----1件: 6 💬
1150NE3107----1件: 6 💬
1151Nebicapone1件: Nebicapone---1件: 6 💬
1152Nelotanserin1件: Nelotanserin1件: Nelotanserin 💬 1件: HTR2A 💬 5件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
1153Neridronic Acid1件: Neridronic Acid---1件: 6 💬
1154NERIXIA*IM EV 1F 25MG----1件: 6 💬
1155Neu-120----1件: 6 💬
1156NEUPRO1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1157Neupro (Reference)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1158NEUPRO 2 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1159Neupro 2 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1160Neupro 2mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1161Neupro 2mg/24h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1162NEUPRO 4 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1163Neupro 4 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1164Neupro 4mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1165Neupro 4mg/24h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1166Neupro 4Mg/24Hr Transdermal Patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1167NEUPRO 6 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1168Neupro 6 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1169Neupro 6mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1170Neupro 6mg/24h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1171NEUPRO 8 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1172Neupro 8 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1173Neupro 8mg/24h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1174NEUPRO*28CER 2MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1175NEUPRO*28CER 4MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1176NEUPRO*28CER 6MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1177NEUPRO*28CER 8MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1178NEUPRO*7CER 4MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1179NEUPRO*7CER 6MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1180NEUPRO*7CER 8MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1181Neupro®1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1182Neupro® 8 mg/24 h1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1183Neuraceq1件: Florbetaben (18F)---1件: 6 💬
1184NEUROBLOC1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
1185NeuroEPO----1件: 6 💬
1186Neurpro----1件: 6 💬
1187Niacin1件: Niacin1件: Niacin 💬 --2件: 6, 78 💬
1188Niacinamide1件: Nicotinamide1件: Niacinamide 💬 --3件: 5, 6, 67 💬
1189Nicorette 10mg/ 16 h1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
1190Nicorette 15 mg/ 16 h1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
1191Nicorette 5 mg/ 16 h1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
1192Nicotinamide1件: Nicotinamide1件: Niacinamide 💬 --8件: 2, 6, 18, 49, 97, 107, 162, 191 💬
1193Nicotinamide riboside2件: Nicotinamide,
Nicotinamide riboside		1件: Niacinamide 💬 --5件: 2, 6, 18, 97, 191 💬
1194NICOTINE1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬3件: 6, 13, 84 💬
1195Nicotine gum1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
1196Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
1197Nicotine patch1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬2件: 6, 84 💬
1198Nicotine transdermal patch1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
1199Nicotinell----1件: 6 💬
1200Nicotinell 17,5 mg/24-Stunden-Pflaster----1件: 6 💬
1201Nicotinell 35 mg/24-Stunden-Pflaster----1件: 6 💬
1202Nilotinib1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬5件: 6, 8, 34, 51, 86 💬
1203Nilotinib 150mg oral capsule [Tasigna]1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
1204Nilotinib 300mg oral capsule [Tasigna]1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
1205NITISINONE1件: Nitisinone1件: Nitisinone 💬 1件: HPD 💬 5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬3件: 6, 164, 241 💬
1206Nitrogen1件: Nitrogen1件: Nitrogen 💬 --5件: 5, 6, 17, 211, 299 💬
1207NLX-112----1件: 6 💬
1208NLY01----1件: 6 💬
1209NMDA1件: Ketamine1件: Ketamine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
1210NO----9件: 6, 46, 58, 62, 86, 97, 222, 299, 321 💬
1211Non intervention-Genetic testing----1件: 6 💬
1212None1件: Interleukin-1 alpha, human recombinant---20件: 6, 46, 51, 65, 66, 78, 84, 85, 96, 97, 140, 160, 161, 171, 222, 231, 246, 271, 299, 337 💬
1213Normal Saline----18件: 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 💬
1214Northera1件: Droxidopa1件: Droxidopa 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1215Nortriptyline1件: Nortriptyline1件: Nortriptyline 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 226 💬
1216Nortriptyline hydrochloride1件: Nortriptyline1件: Nortriptyline 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
1217NPC transplantation----1件: 6 💬
1218NR2B NMDA Antagonist CP-101,606 (traxoprodil)1件: Ketamine1件: Ketamine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
1219NS 2330----1件: 6 💬
1220NS2330----1件: 6 💬
1221NT 101----4件: 5, 6, 7, 17 💬
1222NTCELL Implantation----1件: 6 💬
1223Null----16件: 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
1224NW-1015----1件: 6 💬
1225NW-1015E, EMD 1195686, MSC2191632B----1件: 6 💬
1226NYX-458----1件: 6 💬
1227O-15 Water1件: Water1件: Water 💬 --1件: 6 💬
1228OC oral solution treatment A----1件: 6 💬
1229OC oral solution treatment B----1件: 6 💬
1230OC oral solution treatment C----1件: 6 💬
1231OC oral solution treatment D----1件: 6 💬
1232ODM-101----1件: 6 💬
1233ODM-101 105mg Carbidopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1234ODM-101 65mg Carbidopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1235ODM-104----1件: 6 💬
1236Omeprazole1件: Omeprazole1件: Omeprazole 💬 2件: ATP4A,
ATP4B 💬 		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬14件: 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299 💬
1237Onabotulinumtoxin A Injection----1件: 6 💬
1238OnabotulinumtoxinA1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬4件: 6, 13, 149, 226 💬
1239Ondansetron1件: Ondansetron1件: Ondansetron 💬 5件: HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬 		2件: Serotonergic synapse, Taste transduction 💬3件: 6, 97, 107 💬
1240Ondansetron 8 mg film-coated tablets1件: Ondansetron1件: Ondansetron 💬 5件: HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬 		2件: Serotonergic synapse, Taste transduction 💬1件: 6 💬
1241Ondansetron hydrochloride dihydrate1件: Ondansetron1件: Ondansetron 💬 5件: HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬 		2件: Serotonergic synapse, Taste transduction 💬2件: 6, 97 💬
1242Ongentys1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1243Ongentys 50 mg capsule rigide1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1244Ongentys 50 mg hard capsules1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1245Ongentys 50mg1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1246ONO-2160/CD----1件: 6 💬
1247ONO-2370----1件: 6 💬
1248ONO-2506PO----2件: 2, 6 💬
1249OPC----1件: 6 💬
1250OPICAPONE1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1251Opicapone (OPC)1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1252Opicapone 50 mg1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1253Opicapone 50 mg hard capsules1件: Opicapone1件: Opicapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1254Optimal drug therapy----1件: 6 💬
1255Optimized antiparkinsonian treatment----1件: 6 💬
1256Optimized Medical Treatment----1件: 6 💬
1257Optimized oral treatment----1件: 6 💬
1258Optional pharmacogenetic assessment----1件: 6 💬
1259Oral escitalopram1件: Escitalopram1件: Escitalopram 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
1260Oral levodopa and carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1261Oral Levodopa/Carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1262Orally disintegrating selegiline (Zelapar)1件: Selegiline1件: Selegiline 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1263Orfadin1件: Nitisinone1件: Nitisinone 💬 1件: HPD 💬 5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬2件: 6, 241 💬
1264OSU 6162 similar to (-)-OSU 6162----1件: 6 💬
1265OSU6162 similar to (-)-OSU 6162----2件: 6, 8 💬
1266OTHER NERVOUS SYSTEM DRUGS----2件: 6, 13 💬
1267Other Parkinson's Disease treatments----1件: 6 💬
1268Over-encapsulated Entacapone Tablets1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1269Over-encapsulated Modafinil1件: Modafinil1件: Modafinil 💬 --1件: 6 💬
1270Oxaloacetate1件: Oxaloacetic acid---2件: 6, 11 💬
1271Oxaloacetate (OAA)1件: Oxaloacetic acid---1件: 6 💬
1272OXB-102----1件: 6 💬
1273OXN 10 mg / 5 mg PR----1件: 6 💬
1274OXN 20 mg / 10 mg PR----1件: 6 💬
1275OXN 5 mg/2.5 mg PR----1件: 6 💬
1276Oxybate1件: gamma-Hydroxybutyric acid---2件: 6, 149 💬
1277Oxybuprocaine1件: Oxybuprocaine1件: Oxybuprocaine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
1278Oxybutynin1件: Oxybutynin1件: Oxybutynin 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 13, 53 💬
1279Oxybutynin and darifenacin2件: Darifenacin,
Oxybutynin		2件: Oxybutynin ,
Darifenacin 💬 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
1280Oxybutynin hydrochloride1件: Oxybutynin1件: Oxybutynin 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬2件: 6, 13 💬
1281OXYCODO----1件: 6 💬
1282Oxycodone1件: Oxycodone1件: Oxycodone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 13, 70, 226, 298 💬
1283OXYCODONE HYDROCHLORIDE1件: Oxycodone1件: Oxycodone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬4件: 6, 70, 226, 298 💬
1284Oxycodone/Naloxone Prolonged Release tablets2件: Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1285Oxycodone/naloxone prolonged release tablets 10 mg /5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1286Oxycodone/naloxone prolonged release tablets 20 mg /10 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1287Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1288Oxycontin LP 10mg1件: Oxycodone1件: Oxycodone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1289Oxycontin LP 20mg1件: Oxycodone1件: Oxycodone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1290Oxycontin LP 5mg1件: Oxycodone1件: Oxycodone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1291Oxygen1件: Oxygen1件: Oxygen 💬 --13件: 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330 💬
1292Oxygen-15 Water2件: Oxygen,
Water		2件: Water ,
Oxygen 💬 		--1件: 6 💬
1293Oxytocin1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬7件: 6, 72, 127, 168, 193, 206, 226 💬
1294OXYTOCIN SYNTHETIC1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1295P2B001----1件: 6 💬
1296P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),2件: Pramipexole,
Rasagiline		3件: Pramipexole ,
Rasagiline ,
Rasagiline tartrate 💬 		4件: DRD2,
DRD3,
DRD4,
MAOB 💬 		18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1297P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),2件: Pramipexole,
Rasagiline		3件: Pramipexole ,
Rasagiline ,
Rasagiline tartrate 💬 		4件: DRD2,
DRD3,
DRD4,
MAOB 💬 		18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1298PARACETAMOL1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬6件: 3, 6, 13, 35, 46, 49 💬
1299Parapres----1件: 6 💬
1300PARCOPA2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1301Pardaprunox----1件: 6 💬
1302Pardoprunox1件: Pardoprunox1件: Pardoprunox 💬 3件: DRD2,
DRD3,
HTR1A 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
1303Pardoprunox hydrochloride1件: Pardoprunox1件: Pardoprunox 💬 3件: DRD2,
DRD3,
HTR1A 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
1304Paroxetine1件: Paroxetine1件: Paroxetine 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 6, 13, 46, 85 💬
1305Part 1, JM-010 component Group A----1件: 6 💬
1306Part 1, JM-010 component Group B----1件: 6 💬
1307Part 1, JM-010 component Group C----1件: 6 💬
1308Part 2, JM-010 combination Group A----1件: 6 💬
1309Part 2, JM-010 combination Group B----1件: 6 💬
1310Part 2, JM-010 component Group C----1件: 6 💬
1311PBF-509----1件: 6 💬
1312PD patients H&Y=1.5-2 Medications OFF----1件: 6 💬
1313PD patients H&Y=1.5-2 Medications ON----1件: 6 💬
1314PD patients H&Y=3 Medications OFF----1件: 6 💬
1315PD patients H&Y=3 Medications ON----1件: 6 💬
1316PD vitamin supplementation----1件: 6 💬
1317PEG----15件: 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337 💬
1318Perampanel1件: Perampanel1件: Perampanel 💬 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬 		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬3件: 2, 6, 144 💬
1319PERGOLIDE1件: Pergolide1件: Pergolide 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1320PET----1件: 6 💬
1321PF-06412562----1件: 6 💬
1322PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1323PF-06649751 - 15mg1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1324PF-06649751 - 1mg1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1325PF-06649751 - 5mg1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1326PF-06649751 high dose (15 mg QD)1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1327PF-06649751 low dose (1 mg QD)1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1328PF-06649751 middle dose 1 (3 mg QD)1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1329PF-06649751 middle dose 2 (7 mg QD)1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1330PF-06669571----1件: 6 💬
1331PG203----1件: 6 💬
1332Ph. Eur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid1件: Propanoic acid---1件: 6 💬
1333Ph. Eur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylprop acid----1件: 6 💬
1334Phenlarmide Tablets----1件: 6 💬
1335PHENYLBUTYRATE1件: Phenylbutyric acid---12件: 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338 💬
1336PhEur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid1件: Propanoic acid---1件: 6 💬
1337PhEur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid----1件: 6 💬
1338Phosphate1件: Phosphate ion---32件: 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 💬
1339Piclozotan1件: Piclozotan---1件: 6 💬
1340Pilocarpine1件: Pilocarpine1件: Pilocarpine 💬 2件: CHRM2,
CHRM3 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 53, 299 💬
1341Pimavanserin1件: Pimavanserin---1件: 6 💬
1342Pimavanserin (ACP-103)1件: Pimavanserin---1件: 6 💬
1343Pimavanserin tartrate1件: Pimavanserin---1件: 6 💬
1344Pimavanserin tartrate (ACP-103)1件: Pimavanserin---1件: 6 💬
1345Pioglitazone1件: Pioglitazone1件: Pioglitazone 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
1346Pirepemat----1件: 6 💬
1347Pirepemat x fumarate----1件: 6 💬
1348Pirepemat, 100 mg----1件: 6 💬
1349Pirepemat, 50 mg----1件: 6 💬
1350Piribedil1件: Piribedil1件: Piribedil 💬 2件: DRD2,
DRD3 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1351Piribedil (Clarium)1件: Piribedil1件: Piribedil 💬 2件: DRD2,
DRD3 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1352Pitolisant1件: Pitolisant1件: Pitolisant 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 6, 113, 193 💬
1353PK-Merz----1件: 6 💬
1354PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj1件: Amantadine1件: Amantadine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
1355PKD Patients----1件: 6 💬
1356Placebo----28件: 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
1357Plantago ovata husk----1件: 6 💬
1358Polyethylene glycol1件: Polyethylene glycol1件: Polyethylene glycol 3350 💬 --7件: 6, 78, 96, 97, 235, 276, 299 💬
1359Posiphen1件: Posiphen---1件: 6 💬
1360Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin)1件: Activated charcoal---1件: 6 💬
1361Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin)----1件: 6 💬
1362PR Oxycodone1件: Oxycodone1件: Oxycodone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1363Pramipexol1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1364Pramipexol Extended Release1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1365Pramipexol Immediate Release1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1366Pramipexole1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 2, 6, 20 💬
1367Pramipexole 0.125 mg tablets1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1368Pramipexole 0.5 mg tablets1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1369PRAMIPEXOLE DIHYDROCHLORIDE1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1370Pramipexole dihydrochloride extended-release tablets1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1371PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1372Pramipexole dihydrochloride monohydrate extended release2件: Manganese citrate,
Pramipexole		1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1373Pramipexole ER1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1374Pramipexole Extended Release1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1375Pramipexole extended release tablet1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1376Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole)1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1377Pramipexole Immediate Release1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1378Pramipexole immediate release tablet1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1379Pramipexole IR1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1380Pramipexole or ropinirole2件: Pramipexole,
Ropinirole		2件: Pramipexole ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1381Pramipexole SR1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1382Prasinezumab1件: Prasinezumab1件: Prasinezumab 💬 1件: SNCA 💬 3件: Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 6 💬
1383Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride)1件: Pramipexole1件: Pramipexole 💬 3件: DRD2,
DRD3,
DRD4 💬 		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1384Preladenant1件: Preladenant1件: Preladenant 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1385Preladenant 10 mg tablet1件: Preladenant1件: Preladenant 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1386Preladenant 2 mg tablet1件: Preladenant1件: Preladenant 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1387Preladenant 5 mg tablet1件: Preladenant1件: Preladenant 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1388Premarin ®----1件: 6 💬
1389Pridia (Donepezil Hydrochloride) 5mg1件: Donepezil1件: Donepezil 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
1390Pridia 10mg----1件: 6 💬
1391Pridia 5mg----1件: 6 💬
1392Pridopidine1件: Pridopidine1件: Pridopidine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 2, 6, 8 💬
1393PRIM-DJ2727----2件: 6, 97 💬
1394Primary Cervical Dystonia (Trihexyphenidyl)1件: Trihexyphenidyl1件: Trihexyphenidyl 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
1395Primavanserin tartrate----1件: 6 💬
1396Prior Donepezil 5mg1件: Donepezil1件: Donepezil 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
1397Prior Donzepezil 10mg----1件: 6 💬
1398Probiotic----8件: 2, 6, 93, 96, 97, 193, 266, 299 💬
1399Probiotic Capsule----1件: 6 💬
1400Probiotics----5件: 6, 94, 96, 97, 291 💬
1401Probiotics with prebiotic----1件: 6 💬
1402Prolonged release tablet1件: Manganese citrate---1件: 6 💬
1403Prolopa®----1件: 6 💬
1404Propanoic acid1件: Propanoic acid---2件: 6, 271 💬
1405PROPOFOL1件: Propofol1件: Propofol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬8件: 6, 21, 22, 34, 46, 70, 98, 296 💬
1406Propofol-Lipuro1件: Propofol1件: Propofol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
1407Propranolol1件: Propranolol1件: Propranolol 💬 3件: ADRB1,
ADRB2,
ADRB3 💬 		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 158, 167, 227, 278 💬
1408Propranolol HCl CF 40 mg tablet1件: Propranolol1件: Propranolol 💬 3件: ADRB1,
ADRB2,
ADRB3 💬 		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1409ProSavin----1件: 6 💬
1410PROSCAR*30CPR RIV 5MG1件: Finasteride1件: Finasteride 💬 1件: SRD5A2 💬 3件: Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬1件: 6 💬
1411PRX002----1件: 6 💬
1412PRX002, ELT2, anti-alpha-synuclein monoclonal antibody----1件: 6 💬
1413PS128----1件: 6 💬
1414Psilocybin1件: Psilocybin---1件: 6 💬
1415Psilocybin therapy1件: Psilocybin---1件: 6 💬
1416Psilocybine1件: Psilocybin---1件: 6 💬
1417Psyllium1件: Plantago seed1件: Plantago seed 💬 --3件: 6, 28, 97 💬
1418PT320 2.0 mg----1件: 6 💬
1419PT320 2.5 mg----1件: 6 💬
1420PXT002331----1件: 6 💬
1421PXT002331 - 20mg----1件: 6 💬
1422PXT002331 - dose 1----1件: 6 💬
1423PXT002331 - dose 2----1件: 6 💬
1424PYM50028----1件: 6 💬
1425Pyridostigmine1件: Pyridostigmine---4件: 3, 6, 11, 256 💬
1426Pyridostigmine Bromide1件: Pyridostigmine---3件: 3, 6, 256 💬
1427QSM----1件: 6 💬
1428Quetiapine1件: Quetiapine1件: Quetiapine 💬 2件: DRD2,
HTR2A 💬 		11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬2件: 6, 13 💬
1429R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride1件: Benzofuran---1件: 6 💬
1430R-metHuGDNF1件: Liatermin1件: Liatermin 💬 --1件: 6 💬
1431RAAV-GAD----1件: 6 💬
1432Raclopride1件: Raclopride---4件: 5, 6, 7, 17 💬
1433Racol----3件: 6, 96, 291 💬
1434Radotinib1件: Radotinib---1件: 6 💬
1435Radotinib HCl 50 mg1件: Radotinib---1件: 6 💬
1436Ramelteon1件: Ramelteon1件: Ramelteon 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬3件: 6, 8, 46 💬
1437RAS----3件: 6, 58, 66 💬
1438Rasagilin----2件: 5, 6 💬
1439Rasagilina1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
1440RASAGILINA MESILATO1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
1441Rasagilina mesilato (12 weeks)1件: Rasagiline2件: Rasagiline ,